Literature DB >> 33750831

A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome.

Marija Cvijovic1, Magnus Simrén2,3, Annikka Polster4, Lena Öhman2,5, Julien Tap6, Muriel Derrien6, Boris Le Nevé6, Johanna Sundin2,5, Hans Törnblom2.   

Abstract

Although incompletely understood, microbiota-host interactions are assumed to be altered in irritable bowel syndrome (IBS). We, therefore, aimed to develop a novel analysis pipeline tailored for the integrative analysis of microbiota-host interactions and association to symptoms and prove its utility in a pilot cohort. A multilayer stepwise integrative analysis pipeline was developed to visualize complex variable associations. Application of the pipeline was demonstrated on a dataset of IBS patients and healthy controls (HC), using the R software package to analyze colonic host mRNA and mucosal microbiota (16S rRNA gene sequencing), as well as gastrointestinal (GI) and psychological symptoms. In total, 42 IBS patients (57% female, mean age 33.6 (range 18-58)) and 20 HC (60% female, mean age 26.8 (range 23-41)) were included. Only in IBS patients, mRNA expression of Toll-like receptor 4 and genes associated with barrier function (PAR2, OCLN, TJP1) intercorrelated closely, suggesting potential functional relationships. This host genes-based "permeability cluster" was associated to mucosa-adjacent Chlamydiae and Lentisphaerae, and furthermore associated to satiety as well as to anxiety, depression and fatigue. In both IBS patients and HC, chromogranins, secretogranins and TLRs clustered together. In IBS patients, this host genes-based "immune-enteroendocrine cluster" was associated to specific members of Firmicutes, and to depression and fatigue, whereas in HC no significant association to microbiota was identified. We have developed a stepwise integrative analysis pipeline that allowed identification of unique host-microbiota intercorrelation patterns and association to symptoms in IBS patients. This analysis pipeline may aid in advancing the understanding of complex variable associations in health and disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33750831      PMCID: PMC7943560          DOI: 10.1038/s41598-021-84686-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

Review 1.  High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

Authors:  E G Zoetendal; M Rajilic-Stojanovic; W M de Vos
Journal:  Gut       Date:  2008-11       Impact factor: 23.059

2.  Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis.

Authors:  J J Godon; E Zumstein; P Dabert; F Habouzit; R Moletta
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

Review 3.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 4.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

Review 5.  Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'?

Authors:  Ruchit Sood; Graham R Law; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-07-29       Impact factor: 46.802

Review 6.  Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?

Authors:  Patrick A Hughes; Heddy Zola; Irmeli A Penttila; L Ashley Blackshaw; Jane M Andrews; Doreen Krumbiegel
Journal:  Am J Gastroenterol       Date:  2013-05-07       Impact factor: 10.864

7.  Normalization and microbial differential abundance strategies depend upon data characteristics.

Authors:  Sophie Weiss; Zhenjiang Zech Xu; Shyamal Peddada; Amnon Amir; Kyle Bittinger; Antonio Gonzalez; Catherine Lozupone; Jesse R Zaneveld; Yoshiki Vázquez-Baeza; Amanda Birmingham; Embriette R Hyde; Rob Knight
Journal:  Microbiome       Date:  2017-03-03       Impact factor: 14.650

8.  Comparison of normalization methods for the analysis of metagenomic gene abundance data.

Authors:  Mariana Buongermino Pereira; Mikael Wallroth; Viktor Jonsson; Erik Kristiansson
Journal:  BMC Genomics       Date:  2018-04-20       Impact factor: 3.969

9.  Distinctive probiotic features share common TLR2-dependent signalling in intestinal epithelial cells.

Authors:  Diana Paveljšek; Karolina Ivičak-Kocjan; Primož Treven; Mojca Benčina; Roman Jerala; Irena Rogelj
Journal:  Cell Microbiol       Date:  2020-10-01       Impact factor: 3.715

Review 10.  Review article: the economic impact of the irritable bowel syndrome.

Authors:  C Canavan; J West; T Card
Journal:  Aliment Pharmacol Ther       Date:  2014-09-09       Impact factor: 8.171

View more
  1 in total

1.  Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study.

Authors:  Shreyas V Kumbhare; Patricia A Francis-Lyon; Dashyanng Kachru; Tejaswini Uday; Carmel Irudayanathan; Karthik M Muthukumar; Roshni R Ricchetti; Simitha Singh-Rambiritch; Juan Ugalde; Parambir S Dulai; Daniel E Almonacid; Ranjan Sinha
Journal:  Front Microbiol       Date:  2022-03-21       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.